Mitsui Fudosan and Axil Capital jointly establish the 7 billion yen life sciences-focused CVC fund 'Mitsui Link Fund'
Summary
Mitsui Fudosan and Axil Capital have launched a 7 billion yen life sciences CVC fund called Mitsui Link Fund. The fund will invest in startups across drug discovery, medical devices, regenerative medicine, and healthcare tech from seed to late stage. It combines capital, scientific evaluation, and business development support to help research seeds move into commercialization and growth. The initiative strengthens Mitsui Fudosan’s long-running life sciences ecosystem strategy around facilities, community, and funding.
Funding
Amount
-
Total raised
Date
August 31, 2026
Announcement date
Investors
Mitsui Fudosan, Axil Capital
Lead investors
Company
mitsuifudosan.co.jp
Funded company
AskAI Classifications
Sectors
No sectors detected
Functions
No functions detected